|
OMIM |
Link |
Information gain |
01 |
|
RA
|
[NCBI]
|
0.00186282
|
|
|
AD
|
[NCBI]
|
0.00172133
|
|
|
IS1
|
[NCBI]
|
0.0017115
|
|
|
KLK3
|
[NCBI]
|
0.00168977
|
|
|
ALS5
|
[NCBI]
|
0.00123865
|
|
|
VEGF
|
[NCBI]
|
0.00121579
|
|
|
human immunodeficiency virus type 1, susceptibility to
|
[NCBI]
|
0.000857162
|
|
|
IGAN1
|
[NCBI]
|
0.000839866
|
|
|
DYTCA
|
[NCBI]
|
0.000767725
|
|
|
DFNA24
|
[NCBI]
|
0.000767725
|
|
|
SPOAN
|
[NCBI]
|
0.000767725
|
|
|
SCAR7
|
[NCBI]
|
0.000767725
|
|
|
MPD3
|
[NCBI]
|
0.000550952
|
|
|
restless legs syndrome, susceptibility to, 2
|
[NCBI]
|
0.000550952
|
|
|
SCAR5
|
[NCBI]
|
0.000550952
|
|
|
AMRF
|
[NCBI]
|
0.000550952
|
|
|
hypogonadism, alopecia, diabetes mellitus, mental retardation, and extrapyramidal syndrome
|
[NCBI]
|
0.000469871
|
|
|
IDDM13
|
[NCBI]
|
0.000469871
|
|
|
CRC
|
[NCBI]
|
0.000457007
|
|
|
HMPS1
|
[NCBI]
|
0.000417634
|
|
|
chorioretinal atrophy, progressive bifocal
|
[NCBI]
|
0.000417634
|
|
|
DYT6
|
[NCBI]
|
0.000417634
|
|
|
BRCA3
|
[NCBI]
|
0.000417634
|
|
|
cavitary optic disc anomalies
|
[NCBI]
|
0.000417634
|
|
|
ALSFTD1
|
[NCBI]
|
0.000348624
|
|
|
EGFR
|
[NCBI]
|
0.000342817
|
|
|
glomerulopathy with fibronectin deposits
|
[NCBI]
|
0.000323485
|
|
|
inclusion body myositis
|
[NCBI]
|
0.000323485
|
|
|
FTD
|
[NCBI]
|
0.000310077
|
|
|
hypotrichosis, marie unna type
|
[NCBI]
|
0.000302135
|
|
|
CLN4A
|
[NCBI]
|
0.000302135
|
|
|
AR
|
[NCBI]
|
0.000283765
|
|
|
SPS
|
[NCBI]
|
0.000273757
|
|
|
amyotrophy, monomelic
|
[NCBI]
|
0.000267301
|
|
|
pulmonary alveolar proteinosis, acquired
|
[NCBI]
|
0.000267301
|
|
|
PARK3
|
[NCBI]
|
0.000267301
|
|
|
VRNI
|
[NCBI]
|
0.000246612
|
|
|
renal failure, progressive, with hypertension
|
[NCBI]
|
0.000239615
|
|
|
ZLS
|
[NCBI]
|
0.000239615
|
|
|
epilepsy, myoclonic, benign adult familial, type 1
|
[NCBI]
|
0.000227686
|
|
|
IDDM
|
[NCBI]
|
0.000223746
|
|
|
CBBM
|
[NCBI]
|
0.000216769
|
|
|
DYT2
|
[NCBI]
|
0.000216769
|
|
|
CF
|
[NCBI]
|
0.000216766
|
|
|
sjogren syndrome
|
[NCBI]
|
0.000206717
|
|
|
PD
|
[NCBI]
|
0.000206047
|
|
|
SPP1
|
[NCBI]
|
0.000201837
|
|
|
PRL
|
[NCBI]
|
0.000200292
|
|
|
glaucoma-related pigment dispersion syndrome
|
[NCBI]
|
0.000197417
|
|
|
APOE
|
[NCBI]
|
0.000189408
|
|
|
WM1
|
[NCBI]
|
0.000188773
|
|
|
CRH
|
[NCBI]
|
0.000188298
|
|
|
HGF
|
[NCBI]
|
0.000176152
|
|
|
ALS1
|
[NCBI]
|
0.000176109
|
|
|
MCKD1
|
[NCBI]
|
0.000173158
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
0.000165027
|
|
|
CCR5
|
[NCBI]
|
0.000164355
|
|
|
ILK
|
[NCBI]
|
0.000163806
|
|
|
CDAN2
|
[NCBI]
|
0.000159393
|
|
|
AVP
|
[NCBI]
|
0.00014213
|
|
|
CCK
|
[NCBI]
|
0.000134248
|
|
|
ANG
|
[NCBI]
|
0.000130311
|
|
|
JBTS1
|
[NCBI]
|
0.000126163
|
|
|
COMP
|
[NCBI]
|
0.000125776
|
|
|
MS
|
[NCBI]
|
0.00012136
|
|
|
G6PD
|
[NCBI]
|
0.000120941
|
|
|
PWS
|
[NCBI]
|
0.00011427
|
|
|
polycystic kidneys
|
[NCBI]
|
0.000114009
|
|
|
restless legs syndrome, susceptibility to, 1
|
[NCBI]
|
0.000112871
|
|
|
CJD
|
[NCBI]
|
0.000111976
|
|
|
PTH
|
[NCBI]
|
0.000105998
|
|
|
SOD1
|
[NCBI]
|
9.4934e-05
|
|
|
HLA-B
|
[NCBI]
|
9.42627e-05
|
|
|
MG
|
[NCBI]
|
9.02139e-05
|
|
|
VWM
|
[NCBI]
|
8.45084e-05
|
|
|
KIR3DL1
|
[NCBI]
|
8.25155e-05
|
|
|
PKP3
|
[NCBI]
|
8.25155e-05
|
|
|
ARMD1
|
[NCBI]
|
8.17043e-05
|
|
|
HD
|
[NCBI]
|
7.60207e-05
|
|
|
PFIC2
|
[NCBI]
|
7.57454e-05
|
|
|
coenzyme q10 deficiency
|
[NCBI]
|
7.28581e-05
|
|
|
TH
|
[NCBI]
|
6.99601e-05
|
|
|
MBL2
|
[NCBI]
|
6.98847e-05
|
|
|
PPR
|
[NCBI]
|
6.61064e-05
|
|
|
SHBG
|
[NCBI]
|
6.5641e-05
|
|
|
CLL
|
[NCBI]
|
6.49054e-05
|
|
|
muscular dystrophy, congenital, megaconial type
|
[NCBI]
|
6.46893e-05
|
|
|
EPM3
|
[NCBI]
|
6.46893e-05
|
|
|
DFNB30
|
[NCBI]
|
6.46893e-05
|
|
|
CMD1X
|
[NCBI]
|
6.46893e-05
|
|
|
DFNA28
|
[NCBI]
|
6.46893e-05
|
|
|
glutaric acidemia i
|
[NCBI]
|
6.45918e-05
|
|
|
CD
|
[NCBI]
|
6.43488e-05
|
|
|
CEACAM5
|
[NCBI]
|
6.38035e-05
|
|
|
NPPA
|
[NCBI]
|
6.26103e-05
|
|
|
EAOH
|
[NCBI]
|
5.57693e-05
|
|
|
EIF2B5
|
[NCBI]
|
5.55471e-05
|
|
|
CAT
|
[NCBI]
|
5.54892e-05
|
|
|
behcet syndrome
|
[NCBI]
|
5.53286e-05
|
|
|
MPO
|
[NCBI]
|
5.45405e-05
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 3
|
[NCBI]
|
5.42224e-05
|
|
|
PRX
|
[NCBI]
|
5.32052e-05
|
|
|
EGF
|
[NCBI]
|
5.22967e-05
|
|
|
CFTR
|
[NCBI]
|
5.08375e-05
|
|
|
LPL
|
[NCBI]
|
4.99027e-05
|
|
|
EEA1
|
[NCBI]
|
4.95379e-05
|
|
|
MIRN15A
|
[NCBI]
|
4.95379e-05
|
|
|
NPY
|
[NCBI]
|
4.81581e-05
|
|
|
ABCB11
|
[NCBI]
|
4.76469e-05
|
|
|
MUC1
|
[NCBI]
|
4.72717e-05
|
|
|
CRP
|
[NCBI]
|
4.72382e-05
|
|
|
MIRN16-1
|
[NCBI]
|
4.51824e-05
|
|
|
CCL5
|
[NCBI]
|
4.51824e-05
|
|
|
MTTH
|
[NCBI]
|
4.51824e-05
|
|
|
MRXS13
|
[NCBI]
|
4.47645e-05
|
|
|
PGR
|
[NCBI]
|
4.39653e-05
|
|
|
nephropathy, chronic tubulointerstitial
|
[NCBI]
|
4.2519e-05
|
|
|
myokymia with neonatal epilepsy
|
[NCBI]
|
4.2519e-05
|
|
|
cataract, autosomal dominant
|
[NCBI]
|
4.2519e-05
|
|
|
LGMD2I
|
[NCBI]
|
4.22386e-05
|
|
|
ADA
|
[NCBI]
|
4.18888e-05
|
|
|
mst3- and sok1-related kinase
|
[NCBI]
|
4.12556e-05
|
|
|
ARRB1
|
[NCBI]
|
4.12556e-05
|
|
|
GRHL2
|
[NCBI]
|
4.12556e-05
|
|
|
ITIH5
|
[NCBI]
|
4.12556e-05
|
|
|
SNX1
|
[NCBI]
|
4.12556e-05
|
|
|
U2AF1
|
[NCBI]
|
4.12556e-05
|
|
|
MYO3A
|
[NCBI]
|
4.12556e-05
|
|
|
TGFBR3
|
[NCBI]
|
4.12556e-05
|
|
|
EPHB1
|
[NCBI]
|
4.12556e-05
|
|
|
SULF2
|
[NCBI]
|
4.12556e-05
|
|
|
MSI2
|
[NCBI]
|
4.12556e-05
|
|
|
KCTD7
|
[NCBI]
|
4.12556e-05
|
|
|
PLCB1
|
[NCBI]
|
4.12556e-05
|
|
|
CEP1
|
[NCBI]
|
4.12556e-05
|
|
|
ATG4C
|
[NCBI]
|
4.12556e-05
|
|
|
FAM84A
|
[NCBI]
|
4.12556e-05
|
|
|
WAPAL
|
[NCBI]
|
4.12556e-05
|
|
|
PCNA
|
[NCBI]
|
4.09596e-05
|
|
|
temporal arteritis
|
[NCBI]
|
4.02774e-05
|
|
|
SCA7
|
[NCBI]
|
4.00377e-05
|
|
|
SACS
|
[NCBI]
|
3.99403e-05
|
|
|
PLAUR
|
[NCBI]
|
3.96547e-05
|
|
|
TNFSF6
|
[NCBI]
|
3.88935e-05
|
|
|
ZAP70
|
[NCBI]
|
3.87424e-05
|
|
|
aortic valve disease
|
[NCBI]
|
3.83248e-05
|
|
|
ALS2
|
[NCBI]
|
3.78355e-05
|
|
|
ARPKD
|
[NCBI]
|
3.6692e-05
|
|
|
CTGF
|
[NCBI]
|
3.64382e-05
|
|
|
CLEC4M
|
[NCBI]
|
3.62294e-05
|
|
|
NCOA3
|
[NCBI]
|
3.60633e-05
|
|
|
LGMD2A
|
[NCBI]
|
3.55867e-05
|
|
|
AFP
|
[NCBI]
|
3.54949e-05
|
|
|
CADASIL
|
[NCBI]
|
3.45372e-05
|
|
|
amyloidosis, cerebroarterial, hereditary, iowa type
|
[NCBI]
|
3.43393e-05
|
|
|
PEOA4
|
[NCBI]
|
3.43393e-05
|
|
|
brugada syndrome 2
|
[NCBI]
|
3.43393e-05
|
|
|
diabetic nephropathy, susceptibility to
|
[NCBI]
|
3.43393e-05
|
|
|
ACHE
|
[NCBI]
|
3.26038e-05
|
|
|
MPL
|
[NCBI]
|
3.20899e-05
|
|
|
ALB
|
[NCBI]
|
3.14089e-05
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
3.08751e-05
|
|
|
AS
|
[NCBI]
|
3.08501e-05
|
|
|
EKD1
|
[NCBI]
|
3.04014e-05
|
|
|
CCR2
|
[NCBI]
|
3.0347e-05
|
|
|
TSG101
|
[NCBI]
|
3.0347e-05
|
|
|
PDCD1
|
[NCBI]
|
3.0347e-05
|
|
|
GTS
|
[NCBI]
|
2.95395e-05
|
|
|
alexander disease
|
[NCBI]
|
2.94336e-05
|
|
|
CAMT
|
[NCBI]
|
2.91334e-05
|
|
|
IAHSP
|
[NCBI]
|
2.91334e-05
|
|
|
spongiform encephalopathy with neuropsychiatric features
|
[NCBI]
|
2.91334e-05
|
|
|
LBSL
|
[NCBI]
|
2.91334e-05
|
|
|
ATCAY
|
[NCBI]
|
2.91334e-05
|
|
|
LGMD2K
|
[NCBI]
|
2.91334e-05
|
|
|
LCA5
|
[NCBI]
|
2.91334e-05
|
|
|
BSG
|
[NCBI]
|
2.88742e-05
|
|
|
FKTN
|
[NCBI]
|
2.87706e-05
|
|
|
AGS1
|
[NCBI]
|
2.80715e-05
|
|
|
bethlem myopathy
|
[NCBI]
|
2.80715e-05
|
|
|
BWS
|
[NCBI]
|
2.78126e-05
|
|
|
MAP3K5
|
[NCBI]
|
2.77938e-05
|
|
|
STMN2
|
[NCBI]
|
2.76327e-05
|
|
|
UBIAD1
|
[NCBI]
|
2.76327e-05
|
|
|
ZNF185
|
[NCBI]
|
2.76327e-05
|
|
|
TMEM49
|
[NCBI]
|
2.76327e-05
|
|
|
MDGA1
|
[NCBI]
|
2.76327e-05
|
|
|
MUC2
|
[NCBI]
|
2.76327e-05
|
|
|
SULF1
|
[NCBI]
|
2.76327e-05
|
|
|
ZNF259
|
[NCBI]
|
2.76327e-05
|
|
|
LRRFIP1
|
[NCBI]
|
2.76327e-05
|
|
|
CCNH
|
[NCBI]
|
2.76327e-05
|
|
|
KRT7
|
[NCBI]
|
2.76327e-05
|
|
|
VTCN1
|
[NCBI]
|
2.76327e-05
|
|
|
CCL3L1
|
[NCBI]
|
2.76327e-05
|
|
|
STEAP2
|
[NCBI]
|
2.76327e-05
|
|
|
AGTRL1
|
[NCBI]
|
2.76327e-05
|
|
|
XYLT2
|
[NCBI]
|
2.76327e-05
|
|
|
FGFR4
|
[NCBI]
|
2.73336e-05
|
|
|
AMFR
|
[NCBI]
|
2.73336e-05
|
|
|
VIP
|
[NCBI]
|
2.68484e-05
|
|
|
SCA17
|
[NCBI]
|
2.67907e-05
|
|
|
APOB
|
[NCBI]
|
2.66568e-05
|
|
|
WAS
|
[NCBI]
|
2.60256e-05
|
|
|
FOLH1
|
[NCBI]
|
2.56428e-05
|
|
|
FOP
|
[NCBI]
|
2.54052e-05
|
|
|
coats disease
|
[NCBI]
|
2.53399e-05
|
|
|
platelet disorder, familial, with associated myeloid malignancy
|
[NCBI]
|
2.53399e-05
|
|
|
SCA15
|
[NCBI]
|
2.53399e-05
|
|
|
PTGS2
|
[NCBI]
|
2.52934e-05
|
|
|
AMPD1
|
[NCBI]
|
2.47994e-05
|
|
|
UCMD
|
[NCBI]
|
2.44439e-05
|
|
|
POLG
|
[NCBI]
|
2.43229e-05
|
|
|
CPI
|
[NCBI]
|
2.35514e-05
|
|
|
ALD
|
[NCBI]
|
2.31563e-05
|
|
|
CHS
|
[NCBI]
|
2.3106e-05
|
|
|
DCC
|
[NCBI]
|
2.30882e-05
|
|
|
WBS
|
[NCBI]
|
2.26623e-05
|
|
|
EIF4E
|
[NCBI]
|
2.26234e-05
|
|
|
PLK1
|
[NCBI]
|
2.26215e-05
|
|
|
CCR7
|
[NCBI]
|
2.25892e-05
|
|
|
CD24
|
[NCBI]
|
2.25892e-05
|
|
|
DSC1
|
[NCBI]
|
2.25892e-05
|
|
|
TGM3
|
[NCBI]
|
2.25892e-05
|
|
|
PAXIP1
|
[NCBI]
|
2.25892e-05
|
|
|
APLN
|
[NCBI]
|
2.25892e-05
|
|
|
proline-, glutamic acid-, and leucine-rich protein 1
|
[NCBI]
|
2.25892e-05
|
|
|
RPS16
|
[NCBI]
|
2.25892e-05
|
|
|
MIRN27B
|
[NCBI]
|
2.25892e-05
|
|
|
IL8RA
|
[NCBI]
|
2.25892e-05
|
|
|
LCA5
|
[NCBI]
|
2.25892e-05
|
|
|
ROBO3
|
[NCBI]
|
2.25892e-05
|
|
|
GPD1L
|
[NCBI]
|
2.25892e-05
|
|
|
CCL4
|
[NCBI]
|
2.25892e-05
|
|
|
SUV39H1
|
[NCBI]
|
2.25892e-05
|
|
|
NDUFS8
|
[NCBI]
|
2.25892e-05
|
|
|
aromatic l-amino acid decarboxylase deficiency
|
[NCBI]
|
2.23783e-05
|
|
|
charcot-marie-tooth disease, axonal, type 2j
|
[NCBI]
|
2.23783e-05
|
|
|
DFNA11
|
[NCBI]
|
2.23783e-05
|
|
|
PSNP1
|
[NCBI]
|
2.23437e-05
|
|
|
IL1A
|
[NCBI]
|
2.16436e-05
|
|
|
CXCL12
|
[NCBI]
|
2.16436e-05
|
|
|
TSD
|
[NCBI]
|
2.13412e-05
|
|
|
HGFAC
|
[NCBI]
|
2.07255e-05
|
|
|
DFFB
|
[NCBI]
|
2.07255e-05
|
|
|
DFSP
|
[NCBI]
|
2.04326e-05
|
|
|
FA
|
[NCBI]
|
2.01442e-05
|
|
|
NGFB
|
[NCBI]
|
1.99851e-05
|
|
|
CORD3
|
[NCBI]
|
1.99663e-05
|
|
|
PPCRA
|
[NCBI]
|
1.99663e-05
|
|
|
breath-holding spells
|
[NCBI]
|
1.99663e-05
|
|
|
HGPPS
|
[NCBI]
|
1.99663e-05
|
|
|
SANDO
|
[NCBI]
|
1.99663e-05
|
|
|
myopathy, centronuclear, autosomal recessive
|
[NCBI]
|
1.99663e-05
|
|
|
aplastic anemia
|
[NCBI]
|
1.99663e-05
|
|
|
SCA5
|
[NCBI]
|
1.99663e-05
|
|
|
hydroxyacyl-coa dehydrogenase ii deficiency
|
[NCBI]
|
1.99663e-05
|
|
|
IDDM5
|
[NCBI]
|
1.99663e-05
|
|
|
ICA1
|
[NCBI]
|
1.93693e-05
|
|
|
CD63
|
[NCBI]
|
1.93693e-05
|
|
|
EGR3
|
[NCBI]
|
1.93693e-05
|
|
|
CLN5
|
[NCBI]
|
1.93693e-05
|
|
|
COQ2
|
[NCBI]
|
1.93693e-05
|
|
|
TIAM1
|
[NCBI]
|
1.93693e-05
|
|
|
NTN1
|
[NCBI]
|
1.93693e-05
|
|
|
CLTC
|
[NCBI]
|
1.93693e-05
|
|
|
FKHL16
|
[NCBI]
|
1.93693e-05
|
|
|
FEN1
|
[NCBI]
|
1.93693e-05
|
|
|
ITGB6
|
[NCBI]
|
1.93693e-05
|
|
|
ING4
|
[NCBI]
|
1.93693e-05
|
|
|
EZH2
|
[NCBI]
|
1.93693e-05
|
|
|
PALLD
|
[NCBI]
|
1.93693e-05
|
|
|
CNR2
|
[NCBI]
|
1.93693e-05
|
|
|
PON3
|
[NCBI]
|
1.93693e-05
|
|
|
CLDN3
|
[NCBI]
|
1.93693e-05
|
|
|
THY1
|
[NCBI]
|
1.93693e-05
|
|
|
NPTX2
|
[NCBI]
|
1.93693e-05
|
|
|
XYLT1
|
[NCBI]
|
1.93693e-05
|
|
|
CDK9
|
[NCBI]
|
1.93693e-05
|
|
|
GPX3
|
[NCBI]
|
1.93693e-05
|
|
|
CD248
|
[NCBI]
|
1.93693e-05
|
|
|
JRK
|
[NCBI]
|
1.93693e-05
|
|
|
kindlin 1
|
[NCBI]
|
1.93693e-05
|
|
|
PSCA
|
[NCBI]
|
1.93253e-05
|
|
|
MMP9
|
[NCBI]
|
1.93253e-05
|
|
|
RNASE3
|
[NCBI]
|
1.92305e-05
|
|
|
HLA-DQB1
|
[NCBI]
|
1.90497e-05
|
|
|
SFRP1
|
[NCBI]
|
1.90497e-05
|
|
|
SLC6A3
|
[NCBI]
|
1.90447e-05
|
|
|
EPO
|
[NCBI]
|
1.81198e-05
|
|
|
pancreatic cancer, susceptibility to, 1
|
[NCBI]
|
1.79451e-05
|
|
|
FCDT
|
[NCBI]
|
1.79451e-05
|
|
|
creatine deficiency syndrome, x-linked
|
[NCBI]
|
1.79451e-05
|
|
|
CMT4B1
|
[NCBI]
|
1.79451e-05
|
|
|
adenylosuccinase deficiency
|
[NCBI]
|
1.79451e-05
|
|
|
MDC1C
|
[NCBI]
|
1.79451e-05
|
|
|
MPD1
|
[NCBI]
|
1.79451e-05
|
|
|
TF
|
[NCBI]
|
1.78945e-05
|
|
|
FMF
|
[NCBI]
|
1.78579e-05
|
|
|
PI
|
[NCBI]
|
1.77109e-05
|
|
|
PEMT
|
[NCBI]
|
1.75555e-05
|
|
|
IFNG
|
[NCBI]
|
1.75555e-05
|
|
|
CCL21
|
[NCBI]
|
1.75555e-05
|
|
|
TIMP3
|
[NCBI]
|
1.75555e-05
|
|
|
TNFRSF11B
|
[NCBI]
|
1.72089e-05
|
|
|
AURKA
|
[NCBI]
|
1.70154e-05
|
|
|
SIPA1
|
[NCBI]
|
1.70154e-05
|
|
|
AMPH
|
[NCBI]
|
1.70154e-05
|
|
|
ENO1
|
[NCBI]
|
1.70154e-05
|
|
|
PI5
|
[NCBI]
|
1.70154e-05
|
|
|
NOX1
|
[NCBI]
|
1.70154e-05
|
|
|
KLK5
|
[NCBI]
|
1.70154e-05
|
|
|
MLH3
|
[NCBI]
|
1.70154e-05
|
|
|
CTSE
|
[NCBI]
|
1.70154e-05
|
|
|
LGALS1
|
[NCBI]
|
1.70154e-05
|
|
|
CCL11
|
[NCBI]
|
1.70154e-05
|
|
|
SP110
|
[NCBI]
|
1.70154e-05
|
|
|
PTK6
|
[NCBI]
|
1.70154e-05
|
|
|
BIN1
|
[NCBI]
|
1.70154e-05
|
|
|
DNASE1
|
[NCBI]
|
1.70154e-05
|
|
|
CNGA3
|
[NCBI]
|
1.70154e-05
|
|
|
PTK2B
|
[NCBI]
|
1.68667e-05
|
|
|
ARSB
|
[NCBI]
|
1.68667e-05
|
|
|
SMAD4
|
[NCBI]
|
1.68667e-05
|
|
|
TGFB1
|
[NCBI]
|
1.66518e-05
|
|
|
BCNS
|
[NCBI]
|
1.66412e-05
|
|
|
myoclonic epilepsy of lafora
|
[NCBI]
|
1.64533e-05
|
|
|
PCD
|
[NCBI]
|
1.64335e-05
|
|
|
osseous heteroplasia, progressive
|
[NCBI]
|
1.62159e-05
|
|
|
ACHM3
|
[NCBI]
|
1.62159e-05
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 2
|
[NCBI]
|
1.62159e-05
|
|
|
NPHP3
|
[NCBI]
|
1.62159e-05
|
|
|
CMT4B2
|
[NCBI]
|
1.62159e-05
|
|
|
DYT12
|
[NCBI]
|
1.62159e-05
|
|
|
porencephaly, familial
|
[NCBI]
|
1.62159e-05
|
|
|
EDC
|
[NCBI]
|
1.62159e-05
|
|
|
SLC1A2
|
[NCBI]
|
1.62125e-05
|
|
|
SLC18A2
|
[NCBI]
|
1.62125e-05
|
|
|
HLA-DRB1
|
[NCBI]
|
1.62125e-05
|
|
|
AKT1
|
[NCBI]
|
1.55902e-05
|
|
|
ENPEP
|
[NCBI]
|
1.55902e-05
|
|
|
PHKG2
|
[NCBI]
|
1.51717e-05
|
|
|
MAPK8IP1
|
[NCBI]
|
1.51717e-05
|
|
|
MIA
|
[NCBI]
|
1.51717e-05
|
|
|
CDX2
|
[NCBI]
|
1.51717e-05
|
|
|
SNCB
|
[NCBI]
|
1.51717e-05
|
|
|
GJC2
|
[NCBI]
|
1.51717e-05
|
|
|
RPL10
|
[NCBI]
|
1.51717e-05
|
|
|
HOXA9
|
[NCBI]
|
1.51717e-05
|
|
|
WISP3
|
[NCBI]
|
1.51717e-05
|
|
|
CCL7
|
[NCBI]
|
1.51717e-05
|
|
|
VPS13A
|
[NCBI]
|
1.51717e-05
|
|
|
LRP8
|
[NCBI]
|
1.51717e-05
|
|
|
CSF2RB
|
[NCBI]
|
1.51717e-05
|
|
|
FBLN5
|
[NCBI]
|
1.51717e-05
|
|
|
NPHP3
|
[NCBI]
|
1.51717e-05
|
|
|
HABP2
|
[NCBI]
|
1.51717e-05
|
|
|
TG
|
[NCBI]
|
1.51558e-05
|
|
|
gastric cancer
|
[NCBI]
|
1.50919e-05
|
|
|
FKRP
|
[NCBI]
|
1.49974e-05
|
|
|
DYT1
|
[NCBI]
|
1.49974e-05
|
|
|
takayasu arteritis
|
[NCBI]
|
1.47135e-05
|
|
|
hyperferritinemia-cataract syndrome
|
[NCBI]
|
1.47135e-05
|
|
|
CMT4D
|
[NCBI]
|
1.47135e-05
|
|
|
pierson syndrome
|
[NCBI]
|
1.47135e-05
|
|
|
minicore myopathy with external ophthalmoplegia
|
[NCBI]
|
1.47135e-05
|
|
|
CMT4C
|
[NCBI]
|
1.47135e-05
|
|
|
ND
|
[NCBI]
|
1.44213e-05
|
|
|
TS
|
[NCBI]
|
1.43119e-05
|
|
|
KRAS
|
[NCBI]
|
1.4023e-05
|
|
|
KLF4
|
[NCBI]
|
1.38918e-05
|
|
|
CAST
|
[NCBI]
|
1.36651e-05
|
|
|
TREM2
|
[NCBI]
|
1.36651e-05
|
|
|
NHLRC1
|
[NCBI]
|
1.36651e-05
|
|
|
SAG
|
[NCBI]
|
1.36651e-05
|
|
|
TNNI3
|
[NCBI]
|
1.36651e-05
|
|
|
CXCR3
|
[NCBI]
|
1.36651e-05
|
|
|
SOAT1
|
[NCBI]
|
1.36651e-05
|
|
|
ITGAV
|
[NCBI]
|
1.36651e-05
|
|
|
SLC39A4
|
[NCBI]
|
1.36651e-05
|
|
|
TGM2
|
[NCBI]
|
1.36651e-05
|
|
|
PON2
|
[NCBI]
|
1.36651e-05
|
|
|
BCAR1
|
[NCBI]
|
1.36651e-05
|
|
|
CHEK1
|
[NCBI]
|
1.36651e-05
|
|
|
spinocerebellar ataxia, 16q22-linked
|
[NCBI]
|
1.33922e-05
|
|
|
SCAR1
|
[NCBI]
|
1.33922e-05
|
|
|
PDV
|
[NCBI]
|
1.33922e-05
|
|
|
MMP3
|
[NCBI]
|
1.33754e-05
|
|
|
GPC3
|
[NCBI]
|
1.33754e-05
|
|
|
RB1
|
[NCBI]
|
1.33506e-05
|
|
|
EV
|
[NCBI]
|
1.31929e-05
|
|
|
HPS
|
[NCBI]
|
1.31929e-05
|
|
|
DRPLA
|
[NCBI]
|
1.31929e-05
|
|
|
KSS
|
[NCBI]
|
1.29959e-05
|
|
|
SMAX1
|
[NCBI]
|
1.2983e-05
|
|
|
CP
|
[NCBI]
|
1.28936e-05
|
|
|
FHIT
|
[NCBI]
|
1.28811e-05
|
|
|
FGF7
|
[NCBI]
|
1.27798e-05
|
|
|
IL10
|
[NCBI]
|
1.27136e-05
|
|
|
PTK2
|
[NCBI]
|
1.26587e-05
|
|
|
NF1
|
[NCBI]
|
1.26183e-05
|
|
|
CCL3
|
[NCBI]
|
1.2398e-05
|
|
|
SLC17A7
|
[NCBI]
|
1.2398e-05
|
|
|
PIAS1
|
[NCBI]
|
1.2398e-05
|
|
|
EPHB2
|
[NCBI]
|
1.2398e-05
|
|
|
RTN4
|
[NCBI]
|
1.2398e-05
|
|
|
JMJD6
|
[NCBI]
|
1.2398e-05
|
|
|
PAPPA
|
[NCBI]
|
1.2398e-05
|
|
|
HPSE
|
[NCBI]
|
1.2398e-05
|
|
|
CX3CR1
|
[NCBI]
|
1.2398e-05
|
|
|
SFTPA1
|
[NCBI]
|
1.2398e-05
|
|
|
OLR1
|
[NCBI]
|
1.2398e-05
|
|
|
SLE
|
[NCBI]
|
1.23254e-05
|
|
|
DFNA6
|
[NCBI]
|
1.22189e-05
|
|
|
MTC
|
[NCBI]
|
1.22189e-05
|
|
|
severe cutaneous adverse reaction, susceptibility to
|
[NCBI]
|
1.22189e-05
|
|
|
trifunctional protein deficiency
|
[NCBI]
|
1.22189e-05
|
|
|
encephalopathy, neonatal severe, due to mecp2 mutations
|
[NCBI]
|
1.22189e-05
|
|
|
CLN5
|
[NCBI]
|
1.22189e-05
|
|
|
CMT4A
|
[NCBI]
|
1.22189e-05
|
|
|
SMDP1
|
[NCBI]
|
1.22189e-05
|
|
|
GIST
|
[NCBI]
|
1.21459e-05
|
|
|
amyloidosis vi
|
[NCBI]
|
1.21459e-05
|
|
|
NPC1
|
[NCBI]
|
1.16695e-05
|
|
|
OCP
|
[NCBI]
|
1.16695e-05
|
|
|
SHH
|
[NCBI]
|
1.16564e-05
|
|
|
XDH
|
[NCBI]
|
1.16294e-05
|
|
|
SLC18A3
|
[NCBI]
|
1.15176e-05
|
|
|
HGPS
|
[NCBI]
|
1.13145e-05
|
|
|
CASP3
|
[NCBI]
|
1.13101e-05
|
|
|
ALCAM
|
[NCBI]
|
1.13101e-05
|
|
|
CNGB3
|
[NCBI]
|
1.13101e-05
|
|
|
SFRP4
|
[NCBI]
|
1.13101e-05
|
|
|
HLA-C
|
[NCBI]
|
1.13101e-05
|
|
|
HSD17B4
|
[NCBI]
|
1.13101e-05
|
|
|
TTC10
|
[NCBI]
|
1.13101e-05
|
|
|
SACS
|
[NCBI]
|
1.13101e-05
|
|
|
PDCD4
|
[NCBI]
|
1.13101e-05
|
|
|
SN
|
[NCBI]
|
1.13101e-05
|
|
|
PDCD1LG1
|
[NCBI]
|
1.13101e-05
|
|
|
TRIM25
|
[NCBI]
|
1.13101e-05
|
|
|
SPTLC1
|
[NCBI]
|
1.13101e-05
|
|
|
congenital cataracts, facial dysmorphism, and neuropathy
|
[NCBI]
|
1.11689e-05
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive
|
[NCBI]
|
1.11689e-05
|
|
|
renal tubular acidosis, distal, with progressive nerve deafness
|
[NCBI]
|
1.11689e-05
|
|
|
SEDT
|
[NCBI]
|
1.11689e-05
|
|
|
HFE
|
[NCBI]
|
1.0878e-05
|
|
|
DSG1
|
[NCBI]
|
1.06966e-05
|
|
|
LOX
|
[NCBI]
|
1.06966e-05
|
|
|
CTNNB1
|
[NCBI]
|
1.06966e-05
|
|
|
MAPT
|
[NCBI]
|
1.05431e-05
|
|
|
AHR
|
[NCBI]
|
1.0532e-05
|
|
|
RECK
|
[NCBI]
|
1.03612e-05
|
|
|
ASIP
|
[NCBI]
|
1.03612e-05
|
|
|
C10ORF2
|
[NCBI]
|
1.03612e-05
|
|
|
MEIS1
|
[NCBI]
|
1.03612e-05
|
|
|
FRDA
|
[NCBI]
|
1.03297e-05
|
|
|
mitochondrial dna depletion syndrome, myopathic form
|
[NCBI]
|
1.02232e-05
|
|
|
HOMG3
|
[NCBI]
|
1.02232e-05
|
|
|
HHS
|
[NCBI]
|
1.02232e-05
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
1.00517e-05
|
|
|
HDAC1
|
[NCBI]
|
9.57847e-06
|
|
|
VCP
|
[NCBI]
|
9.57847e-06
|
|
|
CCND1
|
[NCBI]
|
9.56443e-06
|
|
|
ECGF1
|
[NCBI]
|
9.52334e-06
|
|
|
CD14
|
[NCBI]
|
9.52334e-06
|
|
|
MST1
|
[NCBI]
|
9.52334e-06
|
|
|
ANXA1
|
[NCBI]
|
9.52334e-06
|
|
|
METAP2
|
[NCBI]
|
9.52334e-06
|
|
|
MGMT
|
[NCBI]
|
9.52334e-06
|
|
|
CASP1
|
[NCBI]
|
9.52334e-06
|
|
|
CD4
|
[NCBI]
|
9.52334e-06
|
|
|
GJB2
|
[NCBI]
|
9.43066e-06
|
|
|
WGN1
|
[NCBI]
|
9.36682e-06
|
|
|
stuve-wiedemann syndrome
|
[NCBI]
|
9.36682e-06
|
|
|
MAPK8
|
[NCBI]
|
8.7763e-06
|
|
|
MOG
|
[NCBI]
|
8.7763e-06
|
|
|
ZNF9
|
[NCBI]
|
8.7763e-06
|
|
|
MTS
|
[NCBI]
|
8.5878e-06
|
|
|
ACHM2
|
[NCBI]
|
8.5878e-06
|
|
|
kawasaki disease
|
[NCBI]
|
8.5878e-06
|
|
|
BBS
|
[NCBI]
|
8.32542e-06
|
|
|
hypertrophic neuropathy of dejerine-sottas
|
[NCBI]
|
8.14293e-06
|
|
|
DIABLO
|
[NCBI]
|
8.10485e-06
|
|
|
ADAM17
|
[NCBI]
|
8.10485e-06
|
|
|
POMT1
|
[NCBI]
|
8.10485e-06
|
|
|
NEB
|
[NCBI]
|
8.10485e-06
|
|
|
DSG2
|
[NCBI]
|
8.10485e-06
|
|
|
NEU1
|
[NCBI]
|
8.10485e-06
|
|
|
ASL
|
[NCBI]
|
8.10485e-06
|
|
|
BAI1
|
[NCBI]
|
8.10485e-06
|
|
|
KLK7
|
[NCBI]
|
8.10485e-06
|
|
|
ABCB4
|
[NCBI]
|
8.10485e-06
|
|
|
SLC7A5
|
[NCBI]
|
8.10485e-06
|
|
|
glucose transport defect, blood-brain barrier
|
[NCBI]
|
7.87647e-06
|
|
|
DYT3
|
[NCBI]
|
7.87647e-06
|
|
|
myasthenic syndrome, congenital, associated with episodic apnea
|
[NCBI]
|
7.87647e-06
|
|
|
FXTAS
|
[NCBI]
|
7.87647e-06
|
|
|
XFS
|
[NCBI]
|
7.87647e-06
|
|
|
alpers diffuse degeneration of cerebral gray matter with hepatic cirrhosis
|
[NCBI]
|
7.87647e-06
|
|
|
MMP2
|
[NCBI]
|
7.68012e-06
|
|
|
IFNA1
|
[NCBI]
|
7.51127e-06
|
|
|
MTP
|
[NCBI]
|
7.49734e-06
|
|
|
TRAPPC2
|
[NCBI]
|
7.49734e-06
|
|
|
CRX
|
[NCBI]
|
7.49734e-06
|
|
|
MMP12
|
[NCBI]
|
7.49734e-06
|
|
|
COL11A1
|
[NCBI]
|
7.49734e-06
|
|
|
CREM
|
[NCBI]
|
7.49734e-06
|
|
|
PRKCM
|
[NCBI]
|
7.49734e-06
|
|
|
COL11A2
|
[NCBI]
|
7.49734e-06
|
|
|
CCL18
|
[NCBI]
|
7.49734e-06
|
|
|
CTSB
|
[NCBI]
|
7.49734e-06
|
|
|
CAV1
|
[NCBI]
|
7.49734e-06
|
|
|
HGD
|
[NCBI]
|
7.49734e-06
|
|
|
IAPP
|
[NCBI]
|
7.29083e-06
|
|
|
DBA
|
[NCBI]
|
7.28961e-06
|
|
|
SCCMS
|
[NCBI]
|
7.22485e-06
|
|
|
GDNF
|
[NCBI]
|
7.1501e-06
|
|
|
MAS
|
[NCBI]
|
7.12073e-06
|
|
|
TNF
|
[NCBI]
|
7.0953e-06
|
|
|
FSHMD1A
|
[NCBI]
|
7.03527e-06
|
|
|
alsin
|
[NCBI]
|
6.9446e-06
|
|
|
H2AFX
|
[NCBI]
|
6.9446e-06
|
|
|
PTPN22
|
[NCBI]
|
6.9446e-06
|
|
|
ELA2
|
[NCBI]
|
6.9446e-06
|
|
|
PLA2G2A
|
[NCBI]
|
6.9446e-06
|
|
|
TIMP1
|
[NCBI]
|
6.9446e-06
|
|
|
IRF1
|
[NCBI]
|
6.9446e-06
|
|
|
PTPN1
|
[NCBI]
|
6.9446e-06
|
|
|
SDS
|
[NCBI]
|
6.9278e-06
|
|
|
ACE
|
[NCBI]
|
6.8982e-06
|
|
|
CACNA1A
|
[NCBI]
|
6.87044e-06
|
|
|
LCN2
|
[NCBI]
|
6.87044e-06
|
|
|
AMACR
|
[NCBI]
|
6.87044e-06
|
|
|
DYT1
|
[NCBI]
|
6.7572e-06
|
|
|
DM2
|
[NCBI]
|
6.7572e-06
|
|
|
alopecia, androgenetic
|
[NCBI]
|
6.68977e-06
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 1
|
[NCBI]
|
6.62629e-06
|
|
|
BHC
|
[NCBI]
|
6.62629e-06
|
|
|
FHM2
|
[NCBI]
|
6.62629e-06
|
|
|
immunoosseous dysplasia, schimke type
|
[NCBI]
|
6.62629e-06
|
|
|
PTEN
|
[NCBI]
|
6.62258e-06
|
|
|
MJD
|
[NCBI]
|
6.61024e-06
|
|
|
myoclonic epilepsy of unverricht and lundborg
|
[NCBI]
|
6.442e-06
|
|
|
MAPK3
|
[NCBI]
|
6.4393e-06
|
|
|
SIX5
|
[NCBI]
|
6.4393e-06
|
|
|
CD2AP
|
[NCBI]
|
6.4393e-06
|
|
|
PBP
|
[NCBI]
|
6.4393e-06
|
|
|
CFLAR
|
[NCBI]
|
6.4393e-06
|
|
|
PPARD
|
[NCBI]
|
6.4393e-06
|
|
|
CNTF
|
[NCBI]
|
6.29312e-06
|
|
|
NPM1
|
[NCBI]
|
6.23781e-06
|
|
|
FXN
|
[NCBI]
|
6.13861e-06
|
|
|
PARK8
|
[NCBI]
|
6.07521e-06
|
|
|
PLOSL
|
[NCBI]
|
6.07521e-06
|
|
|
MDM2
|
[NCBI]
|
5.97552e-06
|
|
|
KL
|
[NCBI]
|
5.97552e-06
|